{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:15:10Z","timestamp":1793164510645,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3992,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1111\/j.1538-7836.2011.04562.x","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T10:51:45Z","timestamp":1321095105000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria"],"prefix":"10.1016","volume":"10","author":[{"given":"S.T.A.","family":"VAN BIJNEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.L.","family":"VAN HEERDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"MUUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0010","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0015","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","article-title":"Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories","volume":"112","author":"de Latour","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0020","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0025","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","article-title":"Paroxysmal nocturnal haemoglobinuria: long\u2010term follow\u2010up and prognostic factors. French Society of Haematology","volume":"348","author":"Socie","year":"1996","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2011.04562.x_bb0035","first-page":"24","article-title":"High definition contrast\u2010enhanced MR imaging in paroxysmal nocturnal hemoglobinuria (PNH) suggests a high frequency of subclinical thrombosis","volume":"92","author":"Hill","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0040","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood-2003-01-0009","article-title":"Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)","volume":"102","author":"Hall","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","article-title":"Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays","volume":"126","author":"Moyo","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2141.1997.d01-2047.x","article-title":"Glycosylphosphatidyl\u2010inositol (GPI)\u2010linked protein deficiency on the platelets of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils","volume":"96","author":"Jin","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ajh.21141","article-title":"Lysis and thrombosis: manifestation of the same disease","volume":"83","author":"Abou","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0060","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1023\/A:1026467219850","article-title":"Paroxysmal nocturnal hemoglobinuria with no evidence of hemolysis presenting as Budd\u2013Chiari syndrome","volume":"45","author":"Kumar","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH04-06-0391","article-title":"High incidence of thrombosis in African\u2010American and Latin\u2010American patients with paroxysmal nocturnal haemoglobinuria","volume":"93","author":"Araten","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0070","first-page":"885","article-title":"Characteristics of paroxysmal nocturnal hemoglobinuria in China. Clinical analysis of 476 cases","volume":"103","author":"Le","year":"1990","journal-title":"Chin Med J (Engl)"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000126763.68170.46","article-title":"Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan","volume":"83","author":"Nishimura","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1538-7836.2007.02379.x","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview","volume":"5","author":"Ziakas","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1160\/TH07-04-0316","article-title":"Stroke in paroxysmal nocturnal haemoglobinuria: patterns of disease and outcome","volume":"98","author":"Poulou","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0090","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.1525.1525","article-title":"Evaluation of paroxysmal nocturnal hemoglobinuria disease burden: the patient\u2019s perspective","volume":"116","author":"Muus","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0095","first-page":"103","article-title":"Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient","volume":"30","author":"Ray","year":"2000","journal-title":"Haemostasis"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0100","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1160\/TH07-11-0691","article-title":"Monocyte\u2010derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells","volume":"100","author":"Aharon","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0110","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2141.2004.04974.x","article-title":"Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria","volume":"125","author":"Simak","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00001721-200310000-00011","article-title":"Plasmatic coagulation and fibrinolytic system alterations in PNH: relation to clone size","volume":"14","author":"Grunewald","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.2009.016121","article-title":"Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"95","author":"Helley","year":"2010","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0125","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2141.1995.tb05371.x","article-title":"Activated platelets in paroxysmal nocturnal haemoglobinuria","volume":"91","author":"Gralnick","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0130","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0135","first-page":"36","article-title":"Endothelial progenitor cells for vasculogenesis","volume":"20","author":"Murasawa","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0140","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.leu.2405069","article-title":"Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes","volume":"22","author":"la Porta","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3324\/haematol.2010.030288","article-title":"Persistence of recipient\u2010type endothelium after allogeneic hematopoietic stem cell transplantation","volume":"96","author":"Mueller","year":"2011","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0150","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(00)04217-3","article-title":"Repopulation of liver endothelium by bone\u2010marrow\u2010derived cells","volume":"357","author":"Gao","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/01.CIR.0000078642.45127.7B","article-title":"Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0160","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1538-7836.2006.01873.x","article-title":"A GPI\u2010anchored co\u2010receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression","volume":"4","author":"Maroney","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0165","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood-2006-07-037283","article-title":"Active tissue factor pathway inhibitor is expressed on the surface of coated platelets","volume":"109","author":"Maroney","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.thromres.2010.07.014","article-title":"The role of TFPI in regulation of TF\u2010induced thrombogenicity on the surface of human monocytes","volume":"126","author":"Basavaraj","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0175","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1182\/blood-2006-10-055327","article-title":"NB1 mediates surface expression of the ANCA antigen proteinase\u00a03 on human neutrophils","volume":"109","author":"von Vietinghoff","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0180","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3324\/haematol.2010.029298","article-title":"Loss of expression of neutrophil proteinase\u20103: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria","volume":"96","author":"Jankowska","year":"2011","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0185","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood.V89.6.1944","article-title":"Specific inhibition of thrombin\u2010induced cell activation by the neutrophil proteinases elastase, cathepsin\u00a0G, and proteinase\u00a03: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor","volume":"89","author":"Renesto","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0190","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2009-01-195461","article-title":"Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site","volume":"114","author":"Raife","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0195","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1538-7836.2007.02480.x","article-title":"Proteolysis of the endothelial cell protein\u00a0C receptor by neutrophil proteinase\u00a03","volume":"5","author":"Villegas\u2010Mendez","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0200","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1160\/TH08-05-0293","article-title":"Modulation of tissue factor and tissue factor pathway inhibitor\u20101 by neutrophil proteases","volume":"100","author":"Steppich","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0205","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm1410","article-title":"Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency","volume":"12","author":"Almeida","year":"2006","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0210","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.V98.6.1802","article-title":"Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase","volume":"98","author":"Wagener","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","article-title":"Effect of eculizumab on haemolysis\u2010associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria","volume":"149","author":"Hill","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0220","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0049-3848(96)00153-3","article-title":"Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria","volume":"83","author":"Maciejewski","year":"1996","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0225","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1365-2141.1996.d01-1684.x","article-title":"Aplastic anaemia and paroxysmal nocturnal haemoglobinuria: a study of the GPI\u2010anchored proteins on human platelets","volume":"93","author":"Vu","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0230","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0167-5699(91)90012-I","article-title":"The response of human platelets to activated components of the complement system","volume":"12","author":"Sims","year":"1991","journal-title":"Immunol Today"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI112773","article-title":"Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in\u00a0vivo","volume":"79","author":"Devine","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0240","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s002770100350","article-title":"Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuria","volume":"80","author":"Louwes","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0245","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2005-02-0564","article-title":"Sustained response and long\u2010term safety of eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Hill","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0250","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","article-title":"Long term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/scel.1995.0037","article-title":"Induction of cellular procoagulant activity by the membrane attack complex of complement","volume":"6","author":"Sims","year":"1995","journal-title":"Semin Cell Biol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0260","doi-asserted-by":"crossref","first-page":"19228","DOI":"10.1016\/S0021-9258(19)47291-8","article-title":"Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b\u20139 complex","volume":"264","author":"Sims","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0265","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V82.4.1192.1192","article-title":"Complement\u2010induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria","volume":"82","author":"Wiedmer","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09537105310001657110","article-title":"The platelet function defect of paroxysmal nocturnal haemoglobinuria","volume":"15","author":"Grunewald","year":"2004","journal-title":"Platelets"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0275","first-page":"22","article-title":"Membrane microparticles: two sides of the coin","volume":"20","author":"Hugel","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0280","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood.V89.4.1121","article-title":"Pathophysiologic implications of membrane phospholipid asymmetry in blood cells","volume":"89","author":"Zwaal","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0285","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V93.10.3451.410k27_3451_3456","article-title":"Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia","volume":"93","author":"Hugel","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0290","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Owens","year":"2011","journal-title":"Circ Res"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.thromres.2003.09.018","article-title":"Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte\u2010derived tissue factor","volume":"111","author":"Liebman","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0300","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2141.1999.01483.x","article-title":"Complement\u2010induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH","volume":"106","author":"Ninomiya","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0305","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2141.2010.08505.x","article-title":"Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria","volume":"152","author":"Kozuma","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1024\/0301-1526\/a000081","article-title":"Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis","volume":"40","author":"Steppich","year":"2011","journal-title":"Vasa"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0315","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.thromres.2010.07.006","article-title":"Plasma levels of microparticle\u2010associated tissue factor activity in patients with clinically suspected pulmonary embolism","volume":"126","author":"Garcia","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0320","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","article-title":"Tumor\u2010derived tissue factor\u2010bearing microparticles are associated with venous thromboembolic events in malignancy","volume":"15","author":"Zwicker","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0325","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00277-010-1111-1","article-title":"Circulating procoagulant microparticles in cancer patients","volume":"90","author":"Thaler","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0330","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood.V79.6.1447.1447","article-title":"The receptor for urokinase\u2010type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria","volume":"79","author":"Ploug","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0335","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.exphem.2008.06.016","article-title":"Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients","volume":"36","author":"Sloand","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0340","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.1995.tb08366.x","article-title":"The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria","volume":"89","author":"Ronne","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0925-5710(96)00559-2","article-title":"Excess soluble urokinase\u2010type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglobinuria inhibits cell\u2010associated fibrinolytic activity","volume":"65","author":"Ninomiya","year":"1997","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0350","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1073\/pnas.93.12.5899","article-title":"Urokinase\u2010type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue\u2010type plasminogen activator","volume":"93","author":"Bugge","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"10.1111\/j.1538-7836.2011.04562.x_bb0355","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1538-7836.2007.02515.x","article-title":"Vascular bed\u2010specific thrombosis","volume":"5","author":"Aird","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0360","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199905203402007","article-title":"Vascular\u2010bed \u2013 specific hemostasis and hypercoagulable states","volume":"340","author":"Rosenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0365","article-title":"Expression of tissue factor pathway inhibitor (TFPI) by brain endothelium","volume":"112","author":"Maroney","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0370","first-page":"540","article-title":"Factor\u00a0V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis","volume":"81","author":"Nafa","year":"1996","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0375","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1182\/blood.V85.5.1354.bloodjournal8551354","article-title":"Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link","volume":"85","author":"Griscelli\u2010Bennaceur","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0380","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2010.08230.x","article-title":"Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study","volume":"150","author":"Dragoni","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0385","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2009.08022.x","article-title":"Clinical guidelines for testing for heritable thrombophilia","volume":"149","author":"Baglin","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0390","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2141.2011.08665.x","article-title":"Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab","volume":"153","author":"Darnige","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0395","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1160\/TH09-03-0140","article-title":"Absence of JAK2\u2010V617F in paroxysmal nocturnal haemoglobinuria\u2010associated thrombosis","volume":"102","author":"Fouassier","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0400","article-title":"Co\u2010existence of JAKV617F and PIG\u2010A mutations in primary Budd\u2013Chiari syndrome","volume":"114","author":"Sugimori","year":"2009"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0405","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2009.06.019","article-title":"Paroxysmal nocturnal hemoglobinuria in Budd\u2013Chiari syndrome: findings from a cohort study","volume":"51","author":"Hoekstra","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0410","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2011.08690.x","article-title":"Management of paroxysmal nocturnal haemoglobinuria: a personal view","volume":"153","author":"Luzzatto","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0415","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.4239.4239","article-title":"Thrombolytic therapy for reversal of thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)","volume":"116","author":"Araten","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0420","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1160\/TH11-03-0165","article-title":"A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab","volume":"106","author":"Schutgens","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0425","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria","volume":"350","author":"Hillmen","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl. 12","key":"10.1111\/j.1538-7836.2011.04562.x_bb0430","first-page":"ECR40","article-title":"Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria","volume":"90","author":"Hill","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0435","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ajh.21757","article-title":"Long\u2010term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria","volume":"85","author":"Hillmen","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0440","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2008.07183.x","article-title":"Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria","volume":"142","author":"Schubert","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0445","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase\u00a03 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky","year":"2008","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2011.04562.x_bb0450","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/S0049-3848(10)70026-8","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria \u2013 insights into the role of complement in thrombosis","volume":"125","author":"Weitz","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0455","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1182\/blood-2009-03-195966","article-title":"How I treat paroxysmal nocturnal hemoglobinuria","volume":"113","author":"Brodsky","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04562.x_bb0460","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ajh.21506","article-title":"Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria","volume":"84","author":"Emadi","year":"2009","journal-title":"Am J Hematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2011.04562.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622061451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622061451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2011.04562.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:56:52Z","timestamp":1761533812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622061451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1538783622061451"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04562.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04562.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}